市場調査レポート

商品コード

1298364

細胞分析市場：製品別、手法別、用途別、エンドユーザー別：世界の機会分析と産業予測、2023-2032年

Cell Analysis Market By Product, By Technique (Flow cytometry, Mass Spectrometry, Next Generation Sequencing, Polymerase Chain Reaction, Others), By Application, By End User : Global Opportunity Analysis and Industry Forecast, 2023-2032

出版日: 2023年04月01日 | 発行: Allied Market Research

| ページ情報: 英文 249 Pages | 納期: 2～3営業日

価格

PDF (Single User License)

USD 5,730 898,234円

レポートPDFを1つのPCでご利用頂けるライセンスです。ライセンスを付与されたPCでのみレポートPDFの保存、表示、利用が可能です。PDF内のテキスト等のコピー＆ペーストは可能です。PDFの印刷は1回だけ可能です。印刷したレポートの利用もPDFのライセンス保持者になります。回覧のための複製も原則NGです。

PDF (5-user License)

USD 6,450 1,011,102円

レポートPDFを5名でご利用頂けるライセンスです。ライセンスを付与されたPCでのみレポートPDFの保存、表示、利用が可能です。PDF内のテキスト等のコピー＆ペーストは可能です。PDFの印刷は5回可能です。印刷したレポートの利用もPDFのライセンス保持者5名となります。

PDF (Enterprise User License) & Excel (Data Pack) & Free Update

USD 9,600 1,504,896円

レポートPDFとExcel定量データをひとつの企業、及びその子会社でご利用頂けるライセンスです。ライセンスを付与されたPCでのみレポートPDFとExcelの保存、表示、利用が可能です。PDFとExcel内のテキスト等のコピー＆ペーストは可能です。PDFとExcelの印刷回数の制限はありません。印刷したレポートの利用は企業、及びその子会社内にて共有可能です。無料でレポートのアップデートがご利用いただけます。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=156.76円

全表示
概要
図表
目次

概要

サンプル依頼リストに入れる

細胞分析市場は、2022年には171億米ドルと評価され、2023年から2032年までのCAGRは9.5%を示し、2032年には429億米ドルに達すると推定されています。

細胞分析は、個々の細胞の構造、組成、挙動を観察・研究するために用いられます。顕微鏡、フローサイトメトリー、分光光度法、免疫測定法などのさまざまな手法を駆使して、細胞の健康状態や活性に関する情報を得る。病気の検出や診断、治療に対する反応のモニタリング、細胞機能のメカニズムの調査などに利用されます。

市場の成長を促す主な要因は、細胞分析における手法進歩の高まりと、がんや遺伝性疾患などの慢性疾患の有病率の増加です。例えば、世界保健機関（WHO）によると、がんは世界の主要死因であり、2020年には約1,000万人が死亡しています。2020年の患者数で最も多いのは乳がんで226万人、次いで肺がんで221万人となっています。2020年のがん死亡の原因として最も多いのは肺がんで180万人、次いで結腸・直腸がんで91万6千人となっています。さらに、製薬・バイオテクノロジー業界における研究開発活動の急増と個別化医療への注目の高まりが、市場の成長をさらに後押ししています。しかし、細胞分析製品の高価格と熟練した専門家の不足が、今後数年間の市場成長の妨げになると予想されます。逆に、シングルセルシーケンスの高い成長可能性は、予測期間中に市場成長のための多くの機会を提供すると予想されます。

市場の定義と範囲
主な調査結果
- 影響要因
- 主な投資ポケット
ポーターのファイブフォース分析
- 供給企業の交渉力
- 買い手の交渉力
- 代替品の脅威
- 新規参入業者の脅威
- 競合の激しさ
市場力学
- 促進要因
  - 慢性疾患の増加
  - 細胞分析手法の進歩
  - 個別化医療アプローチの人気の高まり
- 阻害要因
  - 単一細胞解析のコスト高
- 機会
  - 単一細胞シーケンスの高い成長性
COVID-19市場への影響分析

第4章細胞分析市場：製品別

概要
- 市場規模と予測
消耗品
- 主要市場動向、成長要因、機会
- 市場規模・予測：地域別
- 市場シェア分析：国別
サービス
- 主な市場動向、成長要因、機会
- 市場規模・予測：地域別
- 市場シェア分析：国別
楽器
- 主要市場動向、成長要因、機会
- 市場規模・予測：地域別
- 市場シェア分析：国別
ソフトウェア
- 主な市場動向、成長要因、機会
- 市場規模・予測：地域別
- 市場シェア分析：国別

第5章細胞分析市場：手法別

概要
- 市場規模と予測
フローサイトメトリー
- 主な市場動向、成長要因、機会
- 市場規模・予測：地域別
- 市場シェア分析：国別
質量分析
- 主な市場動向、成長要因、機会
- 市場規模・予測：地域別
- 市場シェア分析：国別
次世代シーケンサー（NGS）
- 主な市場動向、成長要因、機会
- 市場規模・予測：地域別
- 市場シェア分析：国別
ポリメラーゼ連鎖反応（PCR）
- 主な市場動向、成長要因、機会
- 市場規模・予測：地域別
- 市場シェア分析：国別
その他
- 主な市場動向、成長要因、機会
- 市場規模・予測：地域別
- 市場シェア分析：国別

第6章細胞分析市場：用途別

概要
- 市場規模および予測
オンコロジー
- 主要市場動向、成長要因、機会
- 市場規模・予測：地域別
- 市場シェア分析：国別
免疫学
- 主要市場動向、成長要因、機会
- 市場規模・予測：地域別
- 市場シェア分析：国別
循環器領域
- 主要市場動向、成長要因、機会
- 市場規模・予測：地域別
- 市場シェア分析：国別
遺伝性疾患
- 主な市場動向、成長要因、機会
- 市場規模・予測：地域別
- 市場シェア分析：国別
幹細胞
- 主な市場動向、成長要因、機会
- 市場規模・予測：地域別
- 市場シェア分析：国別
その他
- 主な市場動向、成長要因、機会
- 市場規模・予測：地域別
- 市場シェア分析：国別

第7章細胞分析市場：エンドユーザー別

概要
- 市場規模と予測
バイオテクノロジーおよび製薬企業
- 主要市場動向、成長要因、機会
- 市場規模・予測：地域別
- 市場シェア分析：国別
病院・診断研究所
- 主な市場動向、成長要因、機会
- 市場規模・予測：地域別
- 市場シェア分析：国別
学術・調査研究所
- 主な市場動向、成長要因、機会
- 市場規模・予測：地域別
- 市場シェア分析：国別
その他
- 主な市場動向、成長要因、機会
- 市場規模・予測：地域別
- 市場シェア分析：国別

第8章細胞分析市場：地域別

概要
- 市場規模・予測：地域別
北米
- 主要動向と機会
- 市場規模・予測：製品別
- 市場規模・予測：手法別
- 市場規模・予測：用途別
- 市場規模・予測：エンドユーザー別
- 市場規模・予測：国別
  - 米国
  - 主要市場動向、成長要因、機会
  - 市場規模・予測：製品別
  - 市場規模・予測：手法別
  - 市場規模・予測：用途別
  - 市場規模・予測：エンドユーザー別
  - カナダ
  - 主要市場動向、成長要因、機会
  - 市場規模・予測：製品別
  - 市場規模・予測：手法別
  - 市場規模・予測：用途別
  - 市場規模・予測：エンドユーザー別
  - メキシコ
  - 主要市場動向、成長要因、機会
  - 市場規模・予測：製品別
  - 市場規模・予測：手法別
  - 市場規模・予測：用途別
  - 市場規模・予測：エンドユーザー別
欧州
- 主要動向と機会
- 市場規模・予測：製品別
- 市場規模・予測：手法別
- 市場規模・予測：用途別
- 市場規模・予測：エンドユーザー別
- 市場規模・予測：国別
  - ドイツ
  - 主要市場動向、成長要因、機会
  - 市場規模・予測：製品別
  - 市場規模・予測：手法別
  - 市場規模・予測：用途別
  - 市場規模・予測：エンドユーザー別
  - フランス
  - 主要市場動向、成長要因、機会
  - 市場規模・予測：製品別
  - 市場規模・予測：手法別
  - 市場規模・予測：用途別
  - 市場規模・予測：エンドユーザー別
  - 英国
  - 主要市場動向、成長要因、機会
  - 市場規模・予測：製品別
  - 市場規模・予測：手法別
  - 市場規模・予測：用途別
  - 市場規模・予測：エンドユーザー別
  - イタリア
  - 主要市場動向、成長要因、機会
  - 市場規模・予測：製品別
  - 市場規模・予測：手法別
  - 市場規模・予測：用途別
  - 市場規模・予測：エンドユーザー別
  - スペイン
  - 主要市場動向、成長要因、機会
  - 市場規模・予測：製品別
  - 市場規模・予測：手法別
  - 市場規模・予測：用途別
  - 市場規模・予測：エンドユーザー別
  - その他欧州
  - 主要市場動向、成長要因、機会
  - 市場規模・予測：製品別
  - 市場規模・予測：手法別
  - 市場規模・予測：用途別
  - 市場規模・予測：エンドユーザー別
アジア太平洋地域
- 主要動向と機会
- 市場規模・予測：製品別
- 市場規模・予測：手法別
- 市場規模・予測：用途別
- 市場規模・予測：エンドユーザー別
- 市場規模・予測：国別
  - 日本
  - 主要市場動向、成長要因、機会
  - 市場規模・予測：製品別
  - 市場規模・予測：手法別
  - 市場規模・予測：用途別
  - 市場規模・予測：エンドユーザー別
  - 中国
  - 主要市場動向、成長要因、機会
  - 市場規模・予測：製品別
  - 市場規模・予測：手法別
  - 市場規模・予測：用途別
  - 市場規模・予測：エンドユーザー別
  - オーストラリア
  - 主要市場動向、成長要因、機会
  - 市場規模・予測：製品別
  - 市場規模・予測：手法別
  - 市場規模・予測：用途別
  - 市場規模・予測：エンドユーザー別
  - 韓国
  - 主要市場動向、成長要因、機会
  - 市場規模・予測：製品別
  - 市場規模・予測：手法別
  - 市場規模・予測：用途別
  - 市場規模・予測：エンドユーザー別
  - インド
  - 主要市場動向、成長要因、機会
  - 市場規模・予測：製品別
  - 市場規模・予測：手法別
  - 市場規模・予測：用途別
  - 市場規模・予測：エンドユーザー別
  - その他アジア太平洋地域
  - 主要市場動向、成長要因、機会
  - 市場規模・予測：製品別
  - 市場規模・予測：手法別
  - 市場規模・予測：用途別
  - 市場規模・予測：エンドユーザー別
ラテンアメリカ・中東・アフリカ
- 主要動向と機会
- 市場規模・予測：製品別
- 市場規模・予測：手法別
- 市場規模・予測：用途別
- 市場規模・予測：エンドユーザー別
- 市場規模・予測：国別
  - ブラジル
  - 主要市場動向、成長要因、機会
  - 市場規模・予測：製品別
  - 市場規模・予測：手法別
  - 市場規模・予測：用途別
  - 市場規模・予測：エンドユーザー別
  - サウジアラビア
  - 主要市場動向、成長要因、機会
  - 市場規模・予測：製品別
  - 市場規模・予測：手法別
  - 市場規模・予測：用途別
  - 市場規模・予測：エンドユーザー別
  - 南アフリカ
  - 主要市場動向、成長要因、機会
  - 市場規模・予測：製品別
  - 市場規模・予測：手法別
  - 市場規模・予測：用途別
  - 市場規模・予測：エンドユーザー別
  - その他の地域
  - 主要市場動向、成長要因、機会
  - 市場規模・予測：製品別
  - 市場規模・予測：手法別
  - 市場規模・予測：用途別
  - 市場規模・予測：エンドユーザー別

第9章競合情勢

イントロダクション
主要成功戦略
主要10社の製品マッピング
競合ダッシュボード
競合ヒートマップ
トップ企業のポジショニング、2022年

第10章企業プロファイル

Agilent Technologies, Inc.
Becton, Dickinson and Company
Biomerieux SA
Bio-Rad Laboratories, Inc.
Danaher Corporation
Sartorius AG
Illumina, Inc.
Thermo Fisher Scientific, Inc.
Qiagen N.V.
Standard BioTools Inc.

図表

LIST OF TABLES

TABLE 01. GLOBAL CELL ANALYSIS MARKET, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 02. CELL ANALYSIS MARKET FOR CONSUMABLES, BY REGION, 2022-2032 ($MILLION)
TABLE 03. CELL ANALYSIS MARKET FOR SERVICES, BY REGION, 2022-2032 ($MILLION)
TABLE 04. CELL ANALYSIS MARKET FOR INSTRUMENTS, BY REGION, 2022-2032 ($MILLION)
TABLE 05. CELL ANALYSIS MARKET FOR SOFTWARE, BY REGION, 2022-2032 ($MILLION)
TABLE 06. GLOBAL CELL ANALYSIS MARKET, BY TECHNIQUE, 2022-2032 ($MILLION)
TABLE 07. CELL ANALYSIS MARKET FOR FLOW CYTOMETRY, BY REGION, 2022-2032 ($MILLION)
TABLE 08. CELL ANALYSIS MARKET FOR MASS SPECTROMETRY, BY REGION, 2022-2032 ($MILLION)
TABLE 09. CELL ANALYSIS MARKET FOR NEXT GENERATION SEQUENCING (NGS), BY REGION, 2022-2032 ($MILLION)
TABLE 10. CELL ANALYSIS MARKET FOR POLYMERASE CHAIN REACTION (PCR), BY REGION, 2022-2032 ($MILLION)
TABLE 11. CELL ANALYSIS MARKET FOR OTHERS, BY REGION, 2022-2032 ($MILLION)
TABLE 12. GLOBAL CELL ANALYSIS MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 13. CELL ANALYSIS MARKET FOR ONCOLOGY, BY REGION, 2022-2032 ($MILLION)
TABLE 14. CELL ANALYSIS MARKET FOR IMMUNOLOGY, BY REGION, 2022-2032 ($MILLION)
TABLE 15. CELL ANALYSIS MARKET FOR CARDIOLOGY, BY REGION, 2022-2032 ($MILLION)
TABLE 16. CELL ANALYSIS MARKET FOR GENETIC DISEASE, BY REGION, 2022-2032 ($MILLION)
TABLE 17. CELL ANALYSIS MARKET FOR STEM CELLS, BY REGION, 2022-2032 ($MILLION)
TABLE 18. CELL ANALYSIS MARKET FOR OTHERS, BY REGION, 2022-2032 ($MILLION)
TABLE 19. GLOBAL CELL ANALYSIS MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 20. CELL ANALYSIS MARKET FOR BIOTECHNOLOGY AND PHARMACEUTICAL COMPANIES, BY REGION, 2022-2032 ($MILLION)
TABLE 21. CELL ANALYSIS MARKET FOR HOSPITALS AND DIAGNOSTIC LABORATORIES, BY REGION, 2022-2032 ($MILLION)
TABLE 22. CELL ANALYSIS MARKET FOR ACADEMIC AND RESEARCH LABORATORIES, BY REGION, 2022-2032 ($MILLION)
TABLE 23. CELL ANALYSIS MARKET FOR OTHERS, BY REGION, 2022-2032 ($MILLION)
TABLE 24. CELL ANALYSIS MARKET, BY REGION, 2022-2032 ($MILLION)
TABLE 25. NORTH AMERICA CELL ANALYSIS MARKET, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 26. NORTH AMERICA CELL ANALYSIS MARKET, BY TECHNIQUE, 2022-2032 ($MILLION)
TABLE 27. NORTH AMERICA CELL ANALYSIS MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 28. NORTH AMERICA CELL ANALYSIS MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 29. NORTH AMERICA CELL ANALYSIS MARKET, BY COUNTRY, 2022-2032 ($MILLION)
TABLE 30. U.S. CELL ANALYSIS MARKET, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 31. U.S. CELL ANALYSIS MARKET, BY TECHNIQUE, 2022-2032 ($MILLION)
TABLE 32. U.S. CELL ANALYSIS MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 33. U.S. CELL ANALYSIS MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 34. CANADA CELL ANALYSIS MARKET, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 35. CANADA CELL ANALYSIS MARKET, BY TECHNIQUE, 2022-2032 ($MILLION)
TABLE 36. CANADA CELL ANALYSIS MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 37. CANADA CELL ANALYSIS MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 38. MEXICO CELL ANALYSIS MARKET, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 39. MEXICO CELL ANALYSIS MARKET, BY TECHNIQUE, 2022-2032 ($MILLION)
TABLE 40. MEXICO CELL ANALYSIS MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 41. MEXICO CELL ANALYSIS MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 42. EUROPE CELL ANALYSIS MARKET, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 43. EUROPE CELL ANALYSIS MARKET, BY TECHNIQUE, 2022-2032 ($MILLION)
TABLE 44. EUROPE CELL ANALYSIS MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 45. EUROPE CELL ANALYSIS MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 46. EUROPE CELL ANALYSIS MARKET, BY COUNTRY, 2022-2032 ($MILLION)
TABLE 47. GERMANY CELL ANALYSIS MARKET, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 48. GERMANY CELL ANALYSIS MARKET, BY TECHNIQUE, 2022-2032 ($MILLION)
TABLE 49. GERMANY CELL ANALYSIS MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 50. GERMANY CELL ANALYSIS MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 51. FRANCE CELL ANALYSIS MARKET, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 52. FRANCE CELL ANALYSIS MARKET, BY TECHNIQUE, 2022-2032 ($MILLION)
TABLE 53. FRANCE CELL ANALYSIS MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 54. FRANCE CELL ANALYSIS MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 55. UK CELL ANALYSIS MARKET, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 56. UK CELL ANALYSIS MARKET, BY TECHNIQUE, 2022-2032 ($MILLION)
TABLE 57. UK CELL ANALYSIS MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 58. UK CELL ANALYSIS MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 59. ITALY CELL ANALYSIS MARKET, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 60. ITALY CELL ANALYSIS MARKET, BY TECHNIQUE, 2022-2032 ($MILLION)
TABLE 61. ITALY CELL ANALYSIS MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 62. ITALY CELL ANALYSIS MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 63. SPAIN CELL ANALYSIS MARKET, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 64. SPAIN CELL ANALYSIS MARKET, BY TECHNIQUE, 2022-2032 ($MILLION)
TABLE 65. SPAIN CELL ANALYSIS MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 66. SPAIN CELL ANALYSIS MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 67. REST OF EUROPE CELL ANALYSIS MARKET, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 68. REST OF EUROPE CELL ANALYSIS MARKET, BY TECHNIQUE, 2022-2032 ($MILLION)
TABLE 69. REST OF EUROPE CELL ANALYSIS MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 70. REST OF EUROPE CELL ANALYSIS MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 71. ASIA-PACIFIC CELL ANALYSIS MARKET, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 72. ASIA-PACIFIC CELL ANALYSIS MARKET, BY TECHNIQUE, 2022-2032 ($MILLION)
TABLE 73. ASIA-PACIFIC CELL ANALYSIS MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 74. ASIA-PACIFIC CELL ANALYSIS MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 75. ASIA-PACIFIC CELL ANALYSIS MARKET, BY COUNTRY, 2022-2032 ($MILLION)
TABLE 76. JAPAN CELL ANALYSIS MARKET, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 77. JAPAN CELL ANALYSIS MARKET, BY TECHNIQUE, 2022-2032 ($MILLION)
TABLE 78. JAPAN CELL ANALYSIS MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 79. JAPAN CELL ANALYSIS MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 80. CHINA CELL ANALYSIS MARKET, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 81. CHINA CELL ANALYSIS MARKET, BY TECHNIQUE, 2022-2032 ($MILLION)
TABLE 82. CHINA CELL ANALYSIS MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 83. CHINA CELL ANALYSIS MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 84. AUSTRALIA CELL ANALYSIS MARKET, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 85. AUSTRALIA CELL ANALYSIS MARKET, BY TECHNIQUE, 2022-2032 ($MILLION)
TABLE 86. AUSTRALIA CELL ANALYSIS MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 87. AUSTRALIA CELL ANALYSIS MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 88. SOUTH KOREA CELL ANALYSIS MARKET, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 89. SOUTH KOREA CELL ANALYSIS MARKET, BY TECHNIQUE, 2022-2032 ($MILLION)
TABLE 90. SOUTH KOREA CELL ANALYSIS MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 91. SOUTH KOREA CELL ANALYSIS MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 92. INDIA CELL ANALYSIS MARKET, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 93. INDIA CELL ANALYSIS MARKET, BY TECHNIQUE, 2022-2032 ($MILLION)
TABLE 94. INDIA CELL ANALYSIS MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 95. INDIA CELL ANALYSIS MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 96. REST OF ASIA-PACIFIC CELL ANALYSIS MARKET, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 97. REST OF ASIA-PACIFIC CELL ANALYSIS MARKET, BY TECHNIQUE, 2022-2032 ($MILLION)
TABLE 98. REST OF ASIA-PACIFIC CELL ANALYSIS MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 99. REST OF ASIA-PACIFIC CELL ANALYSIS MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 100. LAMEA CELL ANALYSIS MARKET, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 101. LAMEA CELL ANALYSIS MARKET, BY TECHNIQUE, 2022-2032 ($MILLION)
TABLE 102. LAMEA CELL ANALYSIS MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 103. LAMEA CELL ANALYSIS MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 104. LAMEA CELL ANALYSIS MARKET, BY COUNTRY, 2022-2032 ($MILLION)
TABLE 105. BRAZIL CELL ANALYSIS MARKET, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 106. BRAZIL CELL ANALYSIS MARKET, BY TECHNIQUE, 2022-2032 ($MILLION)
TABLE 107. BRAZIL CELL ANALYSIS MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 108. BRAZIL CELL ANALYSIS MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 109. SAUDI ARABIA CELL ANALYSIS MARKET, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 110. SAUDI ARABIA CELL ANALYSIS MARKET, BY TECHNIQUE, 2022-2032 ($MILLION)
TABLE 111. SAUDI ARABIA CELL ANALYSIS MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 112. SAUDI ARABIA CELL ANALYSIS MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 113. SOUTH AFRICA CELL ANALYSIS MARKET, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 114. SOUTH AFRICA CELL ANALYSIS MARKET, BY TECHNIQUE, 2022-2032 ($MILLION)
TABLE 115. SOUTH AFRICA CELL ANALYSIS MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 116. SOUTH AFRICA CELL ANALYSIS MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 117. REST OF LAMEA CELL ANALYSIS MARKET, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 118. REST OF LAMEA CELL ANALYSIS MARKET, BY TECHNIQUE, 2022-2032 ($MILLION)
TABLE 119. REST OF LAMEA CELL ANALYSIS MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 120. REST OF LAMEA CELL ANALYSIS MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 121. AGILENT TECHNOLOGIES, INC.: KEY EXECUTIVES
TABLE 122. AGILENT TECHNOLOGIES, INC.: COMPANY SNAPSHOT
TABLE 123. AGILENT TECHNOLOGIES, INC.: PRODUCT SEGMENTS
TABLE 124. AGILENT TECHNOLOGIES, INC.: SERVICE SEGMENTS
TABLE 125. AGILENT TECHNOLOGIES, INC.: PRODUCT PORTFOLIO
TABLE 126. AGILENT TECHNOLOGIES, INC.: KEY STRATERGIES
TABLE 127. BECTON, DICKINSON AND COMPANY: KEY EXECUTIVES
TABLE 128. BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT
TABLE 129. BECTON, DICKINSON AND COMPANY: PRODUCT SEGMENTS
TABLE 130. BECTON, DICKINSON AND COMPANY: PRODUCT PORTFOLIO
TABLE 131. BECTON, DICKINSON AND COMPANY: KEY STRATERGIES
TABLE 132. BIOMERIEUX SA: KEY EXECUTIVES
TABLE 133. BIOMERIEUX SA: COMPANY SNAPSHOT
TABLE 134. BIOMERIEUX SA: PRODUCT SEGMENTS
TABLE 135. BIOMERIEUX SA: PRODUCT PORTFOLIO
TABLE 136. BIOMERIEUX SA: KEY STRATERGIES
TABLE 137. BIO-RAD LABORATORIES, INC. : KEY EXECUTIVES
TABLE 138. BIO-RAD LABORATORIES, INC. : COMPANY SNAPSHOT
TABLE 139. BIO-RAD LABORATORIES, INC. : PRODUCT SEGMENTS
TABLE 140. BIO-RAD LABORATORIES, INC. : PRODUCT PORTFOLIO
TABLE 141. BIO-RAD LABORATORIES, INC. : KEY STRATERGIES
TABLE 142. DANAHER CORPORATION: KEY EXECUTIVES
TABLE 143. DANAHER CORPORATION: COMPANY SNAPSHOT
TABLE 144. DANAHER CORPORATION: PRODUCT SEGMENTS
TABLE 145. DANAHER CORPORATION: PRODUCT PORTFOLIO
TABLE 146. DANAHER CORPORATION: KEY STRATERGIES
TABLE 147. SARTORIUS AG: KEY EXECUTIVES
TABLE 148. SARTORIUS AG: COMPANY SNAPSHOT
TABLE 149. SARTORIUS AG: PRODUCT SEGMENTS
TABLE 150. SARTORIUS AG: PRODUCT PORTFOLIO
TABLE 151. SARTORIUS AG: KEY STRATERGIES
TABLE 152. ILLUMINA, INC.: KEY EXECUTIVES
TABLE 153. ILLUMINA, INC.: COMPANY SNAPSHOT
TABLE 154. ILLUMINA, INC.: PRODUCT SEGMENTS
TABLE 155. ILLUMINA, INC.: PRODUCT PORTFOLIO
TABLE 156. ILLUMINA, INC.: KEY STRATERGIES
TABLE 157. THERMO FISHER SCIENTIFIC, INC.: KEY EXECUTIVES
TABLE 158. THERMO FISHER SCIENTIFIC, INC.: COMPANY SNAPSHOT
TABLE 159. THERMO FISHER SCIENTIFIC, INC.: SERVICE SEGMENTS
TABLE 160. THERMO FISHER SCIENTIFIC, INC.: PRODUCT PORTFOLIO
TABLE 161. QIAGEN N.V.: KEY EXECUTIVES
TABLE 162. QIAGEN N.V.: COMPANY SNAPSHOT
TABLE 163. QIAGEN N.V.: PRODUCT SEGMENTS
TABLE 164. QIAGEN N.V.: PRODUCT PORTFOLIO
TABLE 165. QIAGEN N.V.: KEY STRATERGIES
TABLE 166. STANDARD BIOTOOLS INC.: KEY EXECUTIVES
TABLE 167. STANDARD BIOTOOLS INC.: COMPANY SNAPSHOT
TABLE 168. STANDARD BIOTOOLS INC.: PRODUCT SEGMENTS
TABLE 169. STANDARD BIOTOOLS INC.: PRODUCT PORTFOLIO
TABLE 170. STANDARD BIOTOOLS INC.: KEY STRATERGIES

LIST OF FIGURES

FIGURE 01. CELL ANALYSIS MARKET, 2022-2032
FIGURE 02. SEGMENTATION OF CELL ANALYSIS MARKET, 2022-2032
FIGURE 03. TOP INVESTMENT POCKETS IN CELL ANALYSIS MARKET (2023-2032)
FIGURE 04. HIGH BARGAINING POWER OF SUPPLIERS
FIGURE 05. MODERATE BARGAINING POWER OF BUYERS
FIGURE 06. MODERATE THREAT OF SUBSTITUTES
FIGURE 07. LOW THREAT OF NEW ENTRANTS
FIGURE 08. MODERATE INTENSITY OF RIVALRY
FIGURE 09. DRIVERS, RESTRAINTS AND OPPORTUNITIES: GLOBALCELL ANALYSIS MARKET
FIGURE 10. CELL ANALYSIS MARKET, BY PRODUCT, 2022(%)
FIGURE 11. COMPARATIVE SHARE ANALYSIS OF CELL ANALYSIS MARKET FOR CONSUMABLES, BY COUNTRY 2022 AND 2032(%)
FIGURE 12. COMPARATIVE SHARE ANALYSIS OF CELL ANALYSIS MARKET FOR SERVICES, BY COUNTRY 2022 AND 2032(%)
FIGURE 13. COMPARATIVE SHARE ANALYSIS OF CELL ANALYSIS MARKET FOR INSTRUMENTS, BY COUNTRY 2022 AND 2032(%)
FIGURE 14. COMPARATIVE SHARE ANALYSIS OF CELL ANALYSIS MARKET FOR SOFTWARE, BY COUNTRY 2022 AND 2032(%)
FIGURE 15. CELL ANALYSIS MARKET, BY TECHNIQUE, 2022(%)
FIGURE 16. COMPARATIVE SHARE ANALYSIS OF CELL ANALYSIS MARKET FOR FLOW CYTOMETRY, BY COUNTRY 2022 AND 2032(%)
FIGURE 17. COMPARATIVE SHARE ANALYSIS OF CELL ANALYSIS MARKET FOR MASS SPECTROMETRY, BY COUNTRY 2022 AND 2032(%)
FIGURE 18. COMPARATIVE SHARE ANALYSIS OF CELL ANALYSIS MARKET FOR NEXT GENERATION SEQUENCING (NGS), BY COUNTRY 2022 AND 2032(%)
FIGURE 19. COMPARATIVE SHARE ANALYSIS OF CELL ANALYSIS MARKET FOR POLYMERASE CHAIN REACTION (PCR), BY COUNTRY 2022 AND 2032(%)
FIGURE 20. COMPARATIVE SHARE ANALYSIS OF CELL ANALYSIS MARKET FOR OTHERS, BY COUNTRY 2022 AND 2032(%)
FIGURE 21. CELL ANALYSIS MARKET, BY APPLICATION, 2022(%)
FIGURE 22. COMPARATIVE SHARE ANALYSIS OF CELL ANALYSIS MARKET FOR ONCOLOGY, BY COUNTRY 2022 AND 2032(%)
FIGURE 23. COMPARATIVE SHARE ANALYSIS OF CELL ANALYSIS MARKET FOR IMMUNOLOGY, BY COUNTRY 2022 AND 2032(%)
FIGURE 24. COMPARATIVE SHARE ANALYSIS OF CELL ANALYSIS MARKET FOR CARDIOLOGY, BY COUNTRY 2022 AND 2032(%)
FIGURE 25. COMPARATIVE SHARE ANALYSIS OF CELL ANALYSIS MARKET FOR GENETIC DISEASE, BY COUNTRY 2022 AND 2032(%)
FIGURE 26. COMPARATIVE SHARE ANALYSIS OF CELL ANALYSIS MARKET FOR STEM CELLS, BY COUNTRY 2022 AND 2032(%)
FIGURE 27. COMPARATIVE SHARE ANALYSIS OF CELL ANALYSIS MARKET FOR OTHERS, BY COUNTRY 2022 AND 2032(%)
FIGURE 28. CELL ANALYSIS MARKET, BY END USER, 2022(%)
FIGURE 29. COMPARATIVE SHARE ANALYSIS OF CELL ANALYSIS MARKET FOR BIOTECHNOLOGY AND PHARMACEUTICAL COMPANIES, BY COUNTRY 2022 AND 2032(%)
FIGURE 30. COMPARATIVE SHARE ANALYSIS OF CELL ANALYSIS MARKET FOR HOSPITALS AND DIAGNOSTIC LABORATORIES, BY COUNTRY 2022 AND 2032(%)
FIGURE 31. COMPARATIVE SHARE ANALYSIS OF CELL ANALYSIS MARKET FOR ACADEMIC AND RESEARCH LABORATORIES, BY COUNTRY 2022 AND 2032(%)
FIGURE 32. COMPARATIVE SHARE ANALYSIS OF CELL ANALYSIS MARKET FOR OTHERS, BY COUNTRY 2022 AND 2032(%)
FIGURE 33. CELL ANALYSIS MARKET BY REGION, 2022
FIGURE 34. U.S. CELL ANALYSIS MARKET, 2022-2032 ($MILLION)
FIGURE 35. CANADA CELL ANALYSIS MARKET, 2022-2032 ($MILLION)
FIGURE 36. MEXICO CELL ANALYSIS MARKET, 2022-2032 ($MILLION)
FIGURE 37. GERMANY CELL ANALYSIS MARKET, 2022-2032 ($MILLION)
FIGURE 38. FRANCE CELL ANALYSIS MARKET, 2022-2032 ($MILLION)
FIGURE 39. UK CELL ANALYSIS MARKET, 2022-2032 ($MILLION)
FIGURE 40. ITALY CELL ANALYSIS MARKET, 2022-2032 ($MILLION)
FIGURE 41. SPAIN CELL ANALYSIS MARKET, 2022-2032 ($MILLION)
FIGURE 42. REST OF EUROPE CELL ANALYSIS MARKET, 2022-2032 ($MILLION)
FIGURE 43. JAPAN CELL ANALYSIS MARKET, 2022-2032 ($MILLION)
FIGURE 44. CHINA CELL ANALYSIS MARKET, 2022-2032 ($MILLION)
FIGURE 45. AUSTRALIA CELL ANALYSIS MARKET, 2022-2032 ($MILLION)
FIGURE 46. SOUTH KOREA CELL ANALYSIS MARKET, 2022-2032 ($MILLION)
FIGURE 47. INDIA CELL ANALYSIS MARKET, 2022-2032 ($MILLION)
FIGURE 48. REST OF ASIA-PACIFIC CELL ANALYSIS MARKET, 2022-2032 ($MILLION)
FIGURE 49. BRAZIL CELL ANALYSIS MARKET, 2022-2032 ($MILLION)
FIGURE 50. SAUDI ARABIA CELL ANALYSIS MARKET, 2022-2032 ($MILLION)
FIGURE 51. SOUTH AFRICA CELL ANALYSIS MARKET, 2022-2032 ($MILLION)
FIGURE 52. REST OF LAMEA CELL ANALYSIS MARKET, 2022-2032 ($MILLION)
FIGURE 53. TOP WINNING STRATEGIES, BY YEAR
FIGURE 54. TOP WINNING STRATEGIES, BY DEVELOPMENT
FIGURE 55. TOP WINNING STRATEGIES, BY COMPANY
FIGURE 56. PRODUCT MAPPING OF TOP 10 PLAYERS
FIGURE 57. COMPETITIVE DASHBOARD
FIGURE 58. COMPETITIVE HEATMAP: CELL ANALYSIS MARKET
FIGURE 59. TOP PLAYER POSITIONING, 2022
FIGURE 60. AGILENT TECHNOLOGIES, INC.: NET REVENUE, 2020-2022 ($MILLION)
FIGURE 61. AGILENT TECHNOLOGIES, INC.: RESEARCH & DEVELOPMENT EXPENDITURE, 2020-2022 ($MILLION)
FIGURE 62. AGILENT TECHNOLOGIES, INC.: REVENUE SHARE BY SEGMENT, 2022 (%)
FIGURE 63. AGILENT TECHNOLOGIES, INC.: REVENUE SHARE BY REGION, 2022 (%)
FIGURE 64. BECTON, DICKINSON AND COMPANY: NET REVENUE, 2020-2022 ($MILLION)
FIGURE 65. BECTON, DICKINSON AND COMPANY: REVENUE SHARE BY SEGMENT, 2022 (%)
FIGURE 66. BECTON, DICKINSON AND COMPANY: REVENUE SHARE BY REGION, 2022 (%)
FIGURE 67. BIOMERIEUX SA: NET SALES, 2019-2021 ($MILLION)
FIGURE 68. BIOMERIEUX SA: REVENUE SHARE BY SEGMENT, 2021 (%)
FIGURE 69. BIOMERIEUX SA: REVENUE SHARE BY REGION, 2021 (%)
FIGURE 70. BIO-RAD LABORATORIES, INC. : NET SALES, 2020-2022 ($MILLION)
FIGURE 71. BIO-RAD LABORATORIES, INC. : REVENUE SHARE BY SEGMENT, 2022 (%)
FIGURE 72. BIO-RAD LABORATORIES, INC. : REVENUE SHARE BY REGION, 2022 (%)
FIGURE 73. DANAHER CORPORATION: NET SALES, 2020-2022 ($MILLION)
FIGURE 74. DANAHER CORPORATION: REVENUE SHARE BY SEGMENT, 2022 (%)
FIGURE 75. DANAHER CORPORATION: REVENUE SHARE BY REGION, 2022 (%)
FIGURE 76. SARTORIUS AG: NET REVENUE, 2020-2022 ($MILLION)
FIGURE 77. SARTORIUS AG: REVENUE SHARE BY SEGMENT, 2022 (%)
FIGURE 78. SARTORIUS AG: REVENUE SHARE BY REGION, 2022 (%)
FIGURE 79. ILLUMINA, INC.: NET REVENUE, 2020-2022 ($MILLION)
FIGURE 80. ILLUMINA, INC.: REVENUE SHARE BY SEGMENT, 2022 (%)
FIGURE 81. ILLUMINA, INC.: REVENUE SHARE BY REGION, 2022 (%)
FIGURE 82. THERMO FISHER SCIENTIFIC, INC.: NET SALES, 2019-2021 ($MILLION)
FIGURE 83. THERMO FISHER SCIENTIFIC, INC.: REVENUE SHARE BY REGION, 2021 (%)
FIGURE 84. THERMO FISHER SCIENTIFIC, INC.: REVENUE SHARE BY SEGMENT, 2021 (%)
FIGURE 85. QIAGEN N.V.: NET REVENUE, 2019-2021 ($MILLION)
FIGURE 86. QIAGEN N.V.: REVENUE SHARE BY REGION, 2021 (%)
FIGURE 87. STANDARD BIOTOOLS INC.: NET REVENUE, 2020-2022 ($MILLION)
FIGURE 88. STANDARD BIOTOOLS INC.: REVENUE SHARE BY SEGMENT, 2022 (%)
FIGURE 89. STANDARD BIOTOOLS INC.: REVENUE SHARE BY REGION, 2022 (%)

Product Code: A03227

The Cell Analysis Market was valued at $17.1 billion in 2022 and is estimated to reach $42.9 billion by 2032, exhibiting a CAGR of 9.5% from 2023 to 2032. Cell analysis is used to observe and study the structure, composition, and behavior of individual cells. It involves the use of various techniques such as microscopy, flow cytometry, spectrophotometry, and immunoassay to obtain information about the health and activity of cells. It can be used to detect and diagnose diseases, monitor the response to treatments, and investigate the mechanisms of cellular functions.

The major factors that drive the growth of the market are the rise in technological advancement in cell analysis and an increase in the prevalence of chronic diseases such as cancer and genetic disorders. For instance, according to World Health Organization, cancer is a leading cause of death worldwide, which accounted for nearly 10 million deaths in 2020. Breast cancer accounted for the highest number of cases in 2020, with 2.26 million cases, followed by lung cancer with 2.21 million cases. The most common causes of cancer death in 2020 were lung cancer with 1.80 million deaths followed by colon and rectum cancer with 916,000 cases. In addition, the surge in R&D activities in the pharmaceutical & biotechnology industry and rise in focus on personalized medicines further propel the market growth. However, high cost of cell analysis products and the dearth of skilled professionals are anticipated to hamper the market growth in the upcoming years. Conversely, the high growth potential of single-cell sequencing is expected to provide numerous opportunities for market growth during the forecast period.

The cell analysis market is segmented into product, application, technique, end user, and region. By product, the market is bifurcated into consumables, software, services, and instruments. By application, it is segregated into oncology, immunology, cardiology, stem cell, genetic disease, and others. By technique, the market is categorized into flow cytometry, next-generation sequencing (NGS), polymerase chain reaction (PCR), mass spectrometry, and others. On the basis of end-user, it is divided into academic & research laboratories, biotechnology & pharmaceutical companies, hospitals & diagnostic laboratories, and others. Region-wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

The major companies profiled in the report include: Becton, Dickinson and Company, Danaher Corporation, QIAGEN N.V., Thermo Fisher Scientific, Inc., Illumina, Inc., Bio-Rad Laboratories, Agilent Technologies, Inc., Sartorius AG, Biomerieux SA, and Standard BioTools Inc. Key players operating in the market have adopted product launch, product approval, and collaboration as their key strategies to expand their corporate training market share.

Key Benefits For Stakeholders

This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the cell analysis market analysis from 2022 to 2032 to identify the prevailing cell analysis market opportunities.
Market research is offered along with information related to key drivers, restraints, and opportunities.
Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders to make profit-oriented business decisions and strengthen their supplier-buyer network.
An in-depth analysis of the cell analysis market segmentation assists to determine the prevailing market opportunities.
Major countries in each region are mapped according to their revenue contribution to the global market.
Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
The report includes the analysis of the regional as well as global cell analysis market trends, key players, market segments, application areas, and market growth strategies.

Key Market Segments

By Technique

Flow cytometry
Mass Spectrometry
Next Generation Sequencing (NGS)
Polymerase Chain Reaction (PCR)
Others

By Application

Oncology
Immunology
Cardiology
Genetic Disease
Stem Cells
Others

By Product

Consumables
Services
Instruments
Software

By End User

Biotechnology and Pharmaceutical Companies
Hospitals and Diagnostic Laboratories
Academic and Research Laboratories
Others

By Region

North America
- U.S.
- Canada
- Mexico
Europe
- Germany
- France
- UK
- Italy
- Spain
- Rest of Europe
Asia-Pacific
- Japan
- China
- Australia
- South Korea
- India
- Rest of Asia-Pacific
LAMEA
- Brazil
- Saudi Arabia
- South Africa
- Rest of LAMEA

Key Market Players:

Agilent Technologies, Inc.
Becton, Dickinson and Company
Biomerieux SA
Bio-Rad Laboratories, Inc.
Danaher Corporation
Illumina, Inc.
Qiagen N.V.
Sartorius AG
Standard BioTools Inc.
Thermo Fisher Scientific, Inc.

CHAPTER 1: INTRODUCTION

1.1. Report description
1.2. Key market segments
1.3. Key benefits to the stakeholders
1.4. Research Methodology
- 1.4.1. Primary research
- 1.4.2. Secondary research
- 1.4.3. Analyst tools and models

CHAPTER 2: EXECUTIVE SUMMARY

2.1. CXO Perspective

CHAPTER 3: MARKET OVERVIEW

3.1. Market definition and scope
3.2. Key findings
- 3.2.1. Top impacting factors
- 3.2.2. Top investment pockets
3.3. Porter's five forces analysis
- 3.3.1. Bargaining power of suppliers
- 3.3.2. Bargaining power of buyers
- 3.3.3. Threat of substitutes
- 3.3.4. Threat of new entrants
- 3.3.5. Intensity of rivalry
3.4. Market dynamics
- 3.4.1. Drivers
  - 3.4.1.1. Increase in prevalence of chronic disease
  - 3.4.1.2. Advancement in cell analysis technology
  - 3.4.1.3. Surge in popularity of personalized medicine approach

3.4.2. Restraints
- 3.4.2.1. High cost of single cell analysis

3.4.3. Opportunities
- 3.4.3.1. High growth potential of Single cell sequencing

3.5. COVID-19 Impact Analysis on the market

CHAPTER 4: CELL ANALYSIS MARKET, BY PRODUCT

4.1. Overview
- 4.1.1. Market size and forecast
4.2. Consumables
- 4.2.1. Key market trends, growth factors and opportunities
- 4.2.2. Market size and forecast, by region
- 4.2.3. Market share analysis by country
4.3. Services
- 4.3.1. Key market trends, growth factors and opportunities
- 4.3.2. Market size and forecast, by region
- 4.3.3. Market share analysis by country
4.4. Instruments
- 4.4.1. Key market trends, growth factors and opportunities
- 4.4.2. Market size and forecast, by region
- 4.4.3. Market share analysis by country
4.5. Software
- 4.5.1. Key market trends, growth factors and opportunities
- 4.5.2. Market size and forecast, by region
- 4.5.3. Market share analysis by country

CHAPTER 5: CELL ANALYSIS MARKET, BY TECHNIQUE

5.1. Overview
- 5.1.1. Market size and forecast
5.2. Flow cytometry
- 5.2.1. Key market trends, growth factors and opportunities
- 5.2.2. Market size and forecast, by region
- 5.2.3. Market share analysis by country
5.3. Mass Spectrometry
- 5.3.1. Key market trends, growth factors and opportunities
- 5.3.2. Market size and forecast, by region
- 5.3.3. Market share analysis by country
5.4. Next Generation Sequencing (NGS)
- 5.4.1. Key market trends, growth factors and opportunities
- 5.4.2. Market size and forecast, by region
- 5.4.3. Market share analysis by country
5.5. Polymerase Chain Reaction (PCR)
- 5.5.1. Key market trends, growth factors and opportunities
- 5.5.2. Market size and forecast, by region
- 5.5.3. Market share analysis by country
5.6. Others
- 5.6.1. Key market trends, growth factors and opportunities
- 5.6.2. Market size and forecast, by region
- 5.6.3. Market share analysis by country

CHAPTER 6: CELL ANALYSIS MARKET, BY APPLICATION

6.1. Overview
- 6.1.1. Market size and forecast
6.2. Oncology
- 6.2.1. Key market trends, growth factors and opportunities
- 6.2.2. Market size and forecast, by region
- 6.2.3. Market share analysis by country
6.3. Immunology
- 6.3.1. Key market trends, growth factors and opportunities
- 6.3.2. Market size and forecast, by region
- 6.3.3. Market share analysis by country
6.4. Cardiology
- 6.4.1. Key market trends, growth factors and opportunities
- 6.4.2. Market size and forecast, by region
- 6.4.3. Market share analysis by country
6.5. Genetic Disease
- 6.5.1. Key market trends, growth factors and opportunities
- 6.5.2. Market size and forecast, by region
- 6.5.3. Market share analysis by country
6.6. Stem Cells
- 6.6.1. Key market trends, growth factors and opportunities
- 6.6.2. Market size and forecast, by region
- 6.6.3. Market share analysis by country
6.7. Others
- 6.7.1. Key market trends, growth factors and opportunities
- 6.7.2. Market size and forecast, by region
- 6.7.3. Market share analysis by country

CHAPTER 7: CELL ANALYSIS MARKET, BY END USER

7.1. Overview
- 7.1.1. Market size and forecast
7.2. Biotechnology and Pharmaceutical Companies
- 7.2.1. Key market trends, growth factors and opportunities
- 7.2.2. Market size and forecast, by region
- 7.2.3. Market share analysis by country
7.3. Hospitals and Diagnostic Laboratories
- 7.3.1. Key market trends, growth factors and opportunities
- 7.3.2. Market size and forecast, by region
- 7.3.3. Market share analysis by country
7.4. Academic and Research Laboratories
- 7.4.1. Key market trends, growth factors and opportunities
- 7.4.2. Market size and forecast, by region
- 7.4.3. Market share analysis by country
7.5. Others
- 7.5.1. Key market trends, growth factors and opportunities
- 7.5.2. Market size and forecast, by region
- 7.5.3. Market share analysis by country

CHAPTER 8: CELL ANALYSIS MARKET, BY REGION

8.1. Overview
- 8.1.1. Market size and forecast By Region
8.2. North America
- 8.2.1. Key trends and opportunities
- 8.2.2. Market size and forecast, by Product
- 8.2.3. Market size and forecast, by Technique
- 8.2.4. Market size and forecast, by Application
- 8.2.5. Market size and forecast, by End User
- 8.2.6. Market size and forecast, by country
  - 8.2.6.1. U.S.
  - 8.2.6.1.1. Key market trends, growth factors and opportunities
  - 8.2.6.1.2. Market size and forecast, by Product
  - 8.2.6.1.3. Market size and forecast, by Technique
  - 8.2.6.1.4. Market size and forecast, by Application
  - 8.2.6.1.5. Market size and forecast, by End User
  - 8.2.6.2. Canada
  - 8.2.6.2.1. Key market trends, growth factors and opportunities
  - 8.2.6.2.2. Market size and forecast, by Product
  - 8.2.6.2.3. Market size and forecast, by Technique
  - 8.2.6.2.4. Market size and forecast, by Application
  - 8.2.6.2.5. Market size and forecast, by End User
  - 8.2.6.3. Mexico
  - 8.2.6.3.1. Key market trends, growth factors and opportunities
  - 8.2.6.3.2. Market size and forecast, by Product
  - 8.2.6.3.3. Market size and forecast, by Technique
  - 8.2.6.3.4. Market size and forecast, by Application
  - 8.2.6.3.5. Market size and forecast, by End User
8.3. Europe
- 8.3.1. Key trends and opportunities
- 8.3.2. Market size and forecast, by Product
- 8.3.3. Market size and forecast, by Technique
- 8.3.4. Market size and forecast, by Application
- 8.3.5. Market size and forecast, by End User
- 8.3.6. Market size and forecast, by country
  - 8.3.6.1. Germany
  - 8.3.6.1.1. Key market trends, growth factors and opportunities
  - 8.3.6.1.2. Market size and forecast, by Product
  - 8.3.6.1.3. Market size and forecast, by Technique
  - 8.3.6.1.4. Market size and forecast, by Application
  - 8.3.6.1.5. Market size and forecast, by End User
  - 8.3.6.2. France
  - 8.3.6.2.1. Key market trends, growth factors and opportunities
  - 8.3.6.2.2. Market size and forecast, by Product
  - 8.3.6.2.3. Market size and forecast, by Technique
  - 8.3.6.2.4. Market size and forecast, by Application
  - 8.3.6.2.5. Market size and forecast, by End User
  - 8.3.6.3. UK
  - 8.3.6.3.1. Key market trends, growth factors and opportunities
  - 8.3.6.3.2. Market size and forecast, by Product
  - 8.3.6.3.3. Market size and forecast, by Technique
  - 8.3.6.3.4. Market size and forecast, by Application
  - 8.3.6.3.5. Market size and forecast, by End User
  - 8.3.6.4. Italy
  - 8.3.6.4.1. Key market trends, growth factors and opportunities
  - 8.3.6.4.2. Market size and forecast, by Product
  - 8.3.6.4.3. Market size and forecast, by Technique
  - 8.3.6.4.4. Market size and forecast, by Application
  - 8.3.6.4.5. Market size and forecast, by End User
  - 8.3.6.5. Spain
  - 8.3.6.5.1. Key market trends, growth factors and opportunities
  - 8.3.6.5.2. Market size and forecast, by Product
  - 8.3.6.5.3. Market size and forecast, by Technique
  - 8.3.6.5.4. Market size and forecast, by Application
  - 8.3.6.5.5. Market size and forecast, by End User
  - 8.3.6.6. Rest of Europe
  - 8.3.6.6.1. Key market trends, growth factors and opportunities
  - 8.3.6.6.2. Market size and forecast, by Product
  - 8.3.6.6.3. Market size and forecast, by Technique
  - 8.3.6.6.4. Market size and forecast, by Application
  - 8.3.6.6.5. Market size and forecast, by End User
8.4. Asia-Pacific
- 8.4.1. Key trends and opportunities
- 8.4.2. Market size and forecast, by Product
- 8.4.3. Market size and forecast, by Technique
- 8.4.4. Market size and forecast, by Application
- 8.4.5. Market size and forecast, by End User
- 8.4.6. Market size and forecast, by country
  - 8.4.6.1. Japan
  - 8.4.6.1.1. Key market trends, growth factors and opportunities
  - 8.4.6.1.2. Market size and forecast, by Product
  - 8.4.6.1.3. Market size and forecast, by Technique
  - 8.4.6.1.4. Market size and forecast, by Application
  - 8.4.6.1.5. Market size and forecast, by End User
  - 8.4.6.2. China
  - 8.4.6.2.1. Key market trends, growth factors and opportunities
  - 8.4.6.2.2. Market size and forecast, by Product
  - 8.4.6.2.3. Market size and forecast, by Technique
  - 8.4.6.2.4. Market size and forecast, by Application
  - 8.4.6.2.5. Market size and forecast, by End User
  - 8.4.6.3. Australia
  - 8.4.6.3.1. Key market trends, growth factors and opportunities
  - 8.4.6.3.2. Market size and forecast, by Product
  - 8.4.6.3.3. Market size and forecast, by Technique
  - 8.4.6.3.4. Market size and forecast, by Application
  - 8.4.6.3.5. Market size and forecast, by End User
  - 8.4.6.4. South Korea
  - 8.4.6.4.1. Key market trends, growth factors and opportunities
  - 8.4.6.4.2. Market size and forecast, by Product
  - 8.4.6.4.3. Market size and forecast, by Technique
  - 8.4.6.4.4. Market size and forecast, by Application
  - 8.4.6.4.5. Market size and forecast, by End User
  - 8.4.6.5. India
  - 8.4.6.5.1. Key market trends, growth factors and opportunities
  - 8.4.6.5.2. Market size and forecast, by Product
  - 8.4.6.5.3. Market size and forecast, by Technique
  - 8.4.6.5.4. Market size and forecast, by Application
  - 8.4.6.5.5. Market size and forecast, by End User
  - 8.4.6.6. Rest of Asia-Pacific
  - 8.4.6.6.1. Key market trends, growth factors and opportunities
  - 8.4.6.6.2. Market size and forecast, by Product
  - 8.4.6.6.3. Market size and forecast, by Technique
  - 8.4.6.6.4. Market size and forecast, by Application
  - 8.4.6.6.5. Market size and forecast, by End User
8.5. LAMEA
- 8.5.1. Key trends and opportunities
- 8.5.2. Market size and forecast, by Product
- 8.5.3. Market size and forecast, by Technique
- 8.5.4. Market size and forecast, by Application
- 8.5.5. Market size and forecast, by End User
- 8.5.6. Market size and forecast, by country
  - 8.5.6.1. Brazil
  - 8.5.6.1.1. Key market trends, growth factors and opportunities
  - 8.5.6.1.2. Market size and forecast, by Product
  - 8.5.6.1.3. Market size and forecast, by Technique
  - 8.5.6.1.4. Market size and forecast, by Application
  - 8.5.6.1.5. Market size and forecast, by End User
  - 8.5.6.2. Saudi Arabia
  - 8.5.6.2.1. Key market trends, growth factors and opportunities
  - 8.5.6.2.2. Market size and forecast, by Product
  - 8.5.6.2.3. Market size and forecast, by Technique
  - 8.5.6.2.4. Market size and forecast, by Application
  - 8.5.6.2.5. Market size and forecast, by End User
  - 8.5.6.3. South Africa
  - 8.5.6.3.1. Key market trends, growth factors and opportunities
  - 8.5.6.3.2. Market size and forecast, by Product
  - 8.5.6.3.3. Market size and forecast, by Technique
  - 8.5.6.3.4. Market size and forecast, by Application
  - 8.5.6.3.5. Market size and forecast, by End User
  - 8.5.6.4. Rest of LAMEA
  - 8.5.6.4.1. Key market trends, growth factors and opportunities
  - 8.5.6.4.2. Market size and forecast, by Product
  - 8.5.6.4.3. Market size and forecast, by Technique
  - 8.5.6.4.4. Market size and forecast, by Application
  - 8.5.6.4.5. Market size and forecast, by End User

CHAPTER 9: COMPETITIVE LANDSCAPE

9.1. Introduction
9.2. Top winning strategies
9.3. Product Mapping of Top 10 Player
9.4. Competitive Dashboard
9.5. Competitive Heatmap
9.6. Top player positioning, 2022

CHAPTER 10: COMPANY PROFILES

10.1. Agilent Technologies, Inc.
- 10.1.1. Company overview
- 10.1.2. Key Executives
- 10.1.3. Company snapshot
- 10.1.4. Operating business segments
- 10.1.5. Product portfolio
- 10.1.6. Business performance
- 10.1.7. Key strategic moves and developments
10.2. Becton, Dickinson and Company
- 10.2.1. Company overview
- 10.2.2. Key Executives
- 10.2.3. Company snapshot
- 10.2.4. Operating business segments
- 10.2.5. Product portfolio
- 10.2.6. Business performance
- 10.2.7. Key strategic moves and developments
10.3. Biomerieux SA
- 10.3.1. Company overview
- 10.3.2. Key Executives
- 10.3.3. Company snapshot
- 10.3.4. Operating business segments
- 10.3.5. Product portfolio
- 10.3.6. Business performance
- 10.3.7. Key strategic moves and developments
10.4. Bio-Rad Laboratories, Inc.
- 10.4.1. Company overview
- 10.4.2. Key Executives
- 10.4.3. Company snapshot
- 10.4.4. Operating business segments
- 10.4.5. Product portfolio
- 10.4.6. Business performance
- 10.4.7. Key strategic moves and developments
10.5. Danaher Corporation
- 10.5.1. Company overview
- 10.5.2. Key Executives
- 10.5.3. Company snapshot
- 10.5.4. Operating business segments
- 10.5.5. Product portfolio
- 10.5.6. Business performance
- 10.5.7. Key strategic moves and developments
10.6. Sartorius AG
- 10.6.1. Company overview
- 10.6.2. Key Executives
- 10.6.3. Company snapshot
- 10.6.4. Operating business segments
- 10.6.5. Product portfolio
- 10.6.6. Business performance
- 10.6.7. Key strategic moves and developments
10.7. Illumina, Inc.
- 10.7.1. Company overview
- 10.7.2. Key Executives
- 10.7.3. Company snapshot
- 10.7.4. Operating business segments
- 10.7.5. Product portfolio
- 10.7.6. Business performance
- 10.7.7. Key strategic moves and developments
10.8. Thermo Fisher Scientific, Inc.
- 10.8.1. Company overview
- 10.8.2. Key Executives
- 10.8.3. Company snapshot
- 10.8.4. Operating business segments
- 10.8.5. Product portfolio
- 10.8.6. Business performance
10.9. Qiagen N.V.
- 10.9.1. Company overview
- 10.9.2. Key Executives
- 10.9.3. Company snapshot
- 10.9.4. Operating business segments
- 10.9.5. Product portfolio
- 10.9.6. Business performance
- 10.9.7. Key strategic moves and developments
10.10. Standard BioTools Inc.
- 10.10.1. Company overview
- 10.10.2. Key Executives
- 10.10.3. Company snapshot
- 10.10.4. Operating business segments
- 10.10.5. Product portfolio
- 10.10.6. Business performance
- 10.10.7. Key strategic moves and developments

細胞分析市場：製品別、手法別、用途別、エンドユーザー別：世界の機会分析と産業予測、2023-2032年

Cell Analysis Market By Product, By Technique (Flow cytometry, Mass Spectrometry, Next Generation Sequencing, Polymerase Chain Reaction, Others), By Application, By End User : Global Opportunity Analysis and Industry Forecast, 2023-2032

目次

第1章イントロダクション

第2章エグゼクティブサマリー

第3章市場概要

第4章細胞分析市場：製品別

第5章細胞分析市場：手法別

第6章細胞分析市場：用途別

第7章細胞分析市場：エンドユーザー別

第8章細胞分析市場：地域別

第9章競合情勢

第10章企業プロファイル

LIST OF TABLES

LIST OF FIGURES

Key Benefits For Stakeholders

Key Market Segments

By Technique

By Application

By Product

By End User

By Region

Key Market Players:

TABLE OF CONTENTS

CHAPTER 1: INTRODUCTION

CHAPTER 2: EXECUTIVE SUMMARY

CHAPTER 3: MARKET OVERVIEW

CHAPTER 4: CELL ANALYSIS MARKET, BY PRODUCT

CHAPTER 5: CELL ANALYSIS MARKET, BY TECHNIQUE

CHAPTER 6: CELL ANALYSIS MARKET, BY APPLICATION

CHAPTER 7: CELL ANALYSIS MARKET, BY END USER

CHAPTER 8: CELL ANALYSIS MARKET, BY REGION

CHAPTER 9: COMPETITIVE LANDSCAPE

CHAPTER 10: COMPANY PROFILES

細胞分析市場：製品別、手法別、用途別、エンドユーザー別：世界の機会分析と産業予測、2023-2032年

Cell Analysis Market By Product, By Technique (Flow cytometry, Mass Spectrometry, Next Generation Sequencing, Polymerase Chain Reaction, Others), By Application, By End User : Global Opportunity Analysis and Industry Forecast, 2023-2032

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

第3章 市場概要

第4章 細胞分析市場：製品別

第5章 細胞分析市場：手法別

第6章 細胞分析市場：用途別

第7章 細胞分析市場：エンドユーザー別

第8章 細胞分析市場：地域別

第9章 競合情勢

第10章 企業プロファイル

LIST OF TABLES

LIST OF FIGURES

Key Benefits For Stakeholders

Key Market Segments

By Technique

By Application

By Product

By End User

By Region

Key Market Players:

TABLE OF CONTENTS

CHAPTER 1: INTRODUCTION

CHAPTER 2: EXECUTIVE SUMMARY

CHAPTER 3: MARKET OVERVIEW

CHAPTER 4: CELL ANALYSIS MARKET, BY PRODUCT

CHAPTER 5: CELL ANALYSIS MARKET, BY TECHNIQUE

CHAPTER 6: CELL ANALYSIS MARKET, BY APPLICATION

CHAPTER 7: CELL ANALYSIS MARKET, BY END USER

CHAPTER 8: CELL ANALYSIS MARKET, BY REGION

CHAPTER 9: COMPETITIVE LANDSCAPE

CHAPTER 10: COMPANY PROFILES

第1章イントロダクション

第2章エグゼクティブサマリー

第3章市場概要

第4章細胞分析市場：製品別

第5章細胞分析市場：手法別

第6章細胞分析市場：用途別

第7章細胞分析市場：エンドユーザー別

第8章細胞分析市場：地域別

第9章競合情勢

第10章企業プロファイル